The In Vitro Diagnostics (IVD) Industry represents one of the most lucrative segments in global healthcare industry. The size of the global IVD market was in excess of US$38 Billion in 2007 and studies have shown that by 2010, the IVD market in India alone should reach about US$990 million, or about 3% of the global IVD market. The growth of the IVD market in India is propelled by factors such as the increasing prevalence of chronic and infectious diseases, emerging technologies and increasing patient awareness of the IVD market.
In fact, recent discoveries and innovations in the realm of IVD hold the exciting promise of revolutionizing the healthcare arena. In particular, the evolution of Molecular Diagnostics, Pharmacogenomics, Theranostics, Biomarkers and Point-of-Care (POC) testing expects to have significant impact on patient success rates and overall healthcare cost reduction.
Therefore, this cutting-edge conference will allow medical and research professionals to identify the latest developments in R&D activity, new technologies, strategic approaches, growth forecasts and competitive dynamics of the India IVD market.
Group Presidents, CEOs, COOs, CTOs, MDs, Directors, Vice Presidents, Heads, Senior Managers & Managers from:
• Contract Research Organizations
• Clinical Research Organizations
• Diagnostics Companies
• Pharmaceutical Companies
• Biotechnology Companies
• Life Sciences Companies
• IVD Manufacturers & Distributors
Professionals, Researchers, Specialist and Scientist from:
• Biochemistry
• Haemapathology
• Haematology
• Oncology
• Pathology
• Molecular Genetic
• Human Genetics & Diseases
• Microbiology
• Bloodbank
• Immunology
• Biotechnology
• Infectious Disease & Public Health
• Other diagnostics: CT Scan, Ultrasound, Xray etc
Consultants, Specialist & General Practitioners from:
• Hospitals
• Medical Centres
• Nursing Homes
• Medical Institutions
• Medical Universities
• Medical & Research Colleges
• Pharmacies
Government officials in Medical & Healthcare such as:
• Ministry:
-Ministry of Health and Family
-Ministry of Commerce and Industry
-Food & Drug Administration
-National Good Laboratory Practice Compliance Monitoring Authority
-Drugs Controller General of India
• Departments
-Science & Technologies
-Nanotechnology & Nanoscience
-Drug Control Lab
• Councils
-Science & Engineering Research Council
-Indian Council of Medical Research
• Associations
-Indian Science Congress Association
-Indian Medical Associations
Consultant & Advisors
Investors & Industry players
• India Food & Drug Administration (FDA)
• Ministry of Health & Family Welfare
• National Good Laboratory Practice Compliance Monitoring Authority
• National Accreditation Board for Testing and Calibration Laboratories (NABL)
• Jawaharlal Institute of Chemical Biology
• Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER)
• National Centre for Biological Sciences (NCBS)
• Indian Institute of Chemical Biology
• Cancer Information Centre
• Rajiv Gandhi Centre for Biotechnology
• Institute Genomics & Integrative Biology
• Indian Institute Technology
• National AIDS Institution
• Indian Drug Manufacturers Association
• Indian Council of Medical Research
• Drugs Controller General of India (DCGI)
• Tata Memorial Centre (TMC)
• All India Institute of Medical Sciences (AIIMS)
• Amrita Institute of Medical Sciences (AIMS)
• Escorts Heart Institute & Research Centre
• Apollo Hospital
• Wockhardt Hospitalv
• SIRO Clinpharm Pvt Lt
• Max Neeman International
• Veeda Clinical Research
• Asiatic Clinical Research Pvt Ltd
